Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2011

Open Access 01-12-2011 | Research article

High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury

Authors: Robert A Mooney, Erik R Sampson, Jaclyn Lerea, Randy N Rosier, Michael J Zuscik

Published in: Arthritis Research & Therapy | Issue 6/2011

Login to get access

Abstract

Introduction

Increasing obesity and type 2 diabetes, in part due to the high-fat (HF) Western diet, parallels an increased incidence of osteoarthritis (OA). This study was undertaken to establish a causal relation between the HF diet and accelerated OA progression in a mouse model and to determine the relative roles of weight gain and metabolic dysregulation in this progression.

Methods

Five-week-old C57BL/6 mice were placed on HF (60% kcal) or low-fat (lean, 10% kcal) diets for 8 or 12 weeks before transecting the medial collateral ligament and excising a segment of the medial meniscus of the knee to initiate OA. One group was switched from lean to HF diet at the time of surgery.

Results

Body weight of mice on the HF diet peaked at 45.9 ± 2.1 g compared with 29.9 ± 1.8 g for lean diets, with only those on the HF becoming diabetic. Severity of OA was greater in HF mice, evidenced by the Osteoarthritis Research Society International (OARSI) histopathology initiative scoring method for mice and articular cartilage thickness and area. To assess the importance of weight gain, short- and long-term HF diets were compared with the lean diet. Short- and long-term HF groups outweighed lean controls by 6.2 g and 20.5 g, respectively. Both HF groups became diabetic, and OA progression, evidenced by increased OARSI score, decreased cartilage thickness, and increased osteophyte diameter, was comparably accelerated relative to those of lean controls.

Conclusions

These results demonstrate that the HF diet accelerates progression of OA in a type 2 diabetic mouse model without correlation to weight gain, suggesting that metabolic dysregulation is a comorbid factor in OA-related cartilage degeneration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature. 2001, 414: 782-787. 10.1038/414782a.CrossRefPubMed Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature. 2001, 414: 782-787. 10.1038/414782a.CrossRefPubMed
2.
go back to reference Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF: Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010, 8: 29-10.1186/1478-7954-8-29.PubMedCentralCrossRefPubMed Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF: Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010, 8: 29-10.1186/1478-7954-8-29.PubMedCentralCrossRefPubMed
3.
go back to reference Huang ES, Basu A, O'Grady M, Capretta JC: Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009, 32: 2225-2229. 10.2337/dc09-0459.PubMedCentralCrossRefPubMed Huang ES, Basu A, O'Grady M, Capretta JC: Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009, 32: 2225-2229. 10.2337/dc09-0459.PubMedCentralCrossRefPubMed
4.
go back to reference Arthritis as a potential barrier to physical activity among adults with diabetes: United States, 2005 and 2007. MMWR Morb Mortal Wkly Rep. 2008, 57: 486-489. Arthritis as a potential barrier to physical activity among adults with diabetes: United States, 2005 and 2007. MMWR Morb Mortal Wkly Rep. 2008, 57: 486-489.
5.
go back to reference Dunbar MJ, Howard A, Bogoch ER, Parvizi J, Kreder HJ: Orthopaedics in 2020: predictors of musculoskeletal need. J Bone Joint Surg Am. 2009, 91: 2276-2286. 10.2106/JBJS.H.01521.CrossRefPubMed Dunbar MJ, Howard A, Bogoch ER, Parvizi J, Kreder HJ: Orthopaedics in 2020: predictors of musculoskeletal need. J Bone Joint Surg Am. 2009, 91: 2276-2286. 10.2106/JBJS.H.01521.CrossRefPubMed
6.
go back to reference Fehring TK, Odum SM, Griffin WL, Mason JB, McCoy TH: The obesity epidemic: its effect on total joint arthroplasty. J Arthroplasty. 2007, 22: 71-76.CrossRefPubMed Fehring TK, Odum SM, Griffin WL, Mason JB, McCoy TH: The obesity epidemic: its effect on total joint arthroplasty. J Arthroplasty. 2007, 22: 71-76.CrossRefPubMed
7.
go back to reference Bourne R, Mukhi S, Zhu N, Keresteci M, Marin M: Role of obesity on the risk for total hip or knee arthroplasty. Clin Orthop Relat Res. 2007, 465: 185-188.PubMed Bourne R, Mukhi S, Zhu N, Keresteci M, Marin M: Role of obesity on the risk for total hip or knee arthroplasty. Clin Orthop Relat Res. 2007, 465: 185-188.PubMed
8.
go back to reference Guilak F, Fermor B, Keefe FJ, Kraus VB, Olson SA, Pisetsky DS, Setton LA, Weinberg JB: The role of biomechanics and inflammation in cartilage injury and repair. Clin Orthop Relat Res. 2004, 423: 17-26.CrossRefPubMed Guilak F, Fermor B, Keefe FJ, Kraus VB, Olson SA, Pisetsky DS, Setton LA, Weinberg JB: The role of biomechanics and inflammation in cartilage injury and repair. Clin Orthop Relat Res. 2004, 423: 17-26.CrossRefPubMed
9.
go back to reference Griffin TM, Guilak F: Why is obesity associated with osteoarthritis? Insights from mouse models of obesity. Biorheology. 2008, 45: 387-398.PubMedCentralPubMed Griffin TM, Guilak F: Why is obesity associated with osteoarthritis? Insights from mouse models of obesity. Biorheology. 2008, 45: 387-398.PubMedCentralPubMed
10.
go back to reference Sandell LJ: Obesity and osteoarthritis: is leptin the link?. Arthritis Rheum. 2009, 60: 2858-2860. 10.1002/art.24862.CrossRefPubMed Sandell LJ: Obesity and osteoarthritis: is leptin the link?. Arthritis Rheum. 2009, 60: 2858-2860. 10.1002/art.24862.CrossRefPubMed
11.
go back to reference Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112: 1821-1830.PubMedCentralCrossRefPubMed Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112: 1821-1830.PubMedCentralCrossRefPubMed
12.
go back to reference Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003, 112: 1796-1808.PubMedCentralCrossRefPubMed Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003, 112: 1796-1808.PubMedCentralCrossRefPubMed
13.
go back to reference Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007, 117: 175-184. 10.1172/JCI29881.PubMedCentralCrossRefPubMed Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007, 117: 175-184. 10.1172/JCI29881.PubMedCentralCrossRefPubMed
14.
go back to reference Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002, 87: 2084-2089. 10.1210/jc.87.5.2084.CrossRefPubMed Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002, 87: 2084-2089. 10.1210/jc.87.5.2084.CrossRefPubMed
15.
go back to reference Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993, 259: 87-91. 10.1126/science.7678183.CrossRefPubMed Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993, 259: 87-91. 10.1126/science.7678183.CrossRefPubMed
16.
go back to reference Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N: Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes. 2005, 54: 3458-3465. 10.2337/diabetes.54.12.3458.CrossRefPubMed Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N: Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes. 2005, 54: 3458-3465. 10.2337/diabetes.54.12.3458.CrossRefPubMed
17.
go back to reference Hamilton JS, Powell LA, McMaster C, McMaster D, Trimble ER: Interaction of glucose and long chain fatty acids (C18) on antioxidant defences and free radical damage in porcine vascular smooth muscle cells in vitro. Diabetologia. 2003, 46: 106-114.PubMed Hamilton JS, Powell LA, McMaster C, McMaster D, Trimble ER: Interaction of glucose and long chain fatty acids (C18) on antioxidant defences and free radical damage in porcine vascular smooth muscle cells in vitro. Diabetologia. 2003, 46: 106-114.PubMed
18.
go back to reference Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes. 2004, 53: 1412-1417. 10.2337/diabetes.53.6.1412.CrossRefPubMed Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes. 2004, 53: 1412-1417. 10.2337/diabetes.53.6.1412.CrossRefPubMed
19.
go back to reference Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes. 2003, 52: 1-8. 10.2337/diabetes.52.1.1.CrossRefPubMed Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes. 2003, 52: 1-8. 10.2337/diabetes.52.1.1.CrossRefPubMed
20.
go back to reference Henriksen EJ, Diamond-Stanic MK, Marchionne EM: Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011, 51: 993-999. 10.1016/j.freeradbiomed.2010.12.005.PubMedCentralCrossRefPubMed Henriksen EJ, Diamond-Stanic MK, Marchionne EM: Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011, 51: 993-999. 10.1016/j.freeradbiomed.2010.12.005.PubMedCentralCrossRefPubMed
21.
go back to reference Cicuttini FM, Baker JR, Spector TD: The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol. 1996, 23: 1221-1226.PubMed Cicuttini FM, Baker JR, Spector TD: The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol. 1996, 23: 1221-1226.PubMed
22.
go back to reference Lohmander LS, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Engstrom G: Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis. 2009, 68: 490-496. 10.1136/ard.2008.089748.CrossRefPubMed Lohmander LS, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Engstrom G: Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis. 2009, 68: 490-496. 10.1136/ard.2008.089748.CrossRefPubMed
23.
go back to reference Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM: Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology. 1999, 10: 161-166. 10.1097/00001648-199903000-00013.CrossRefPubMed Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM: Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology. 1999, 10: 161-166. 10.1097/00001648-199903000-00013.CrossRefPubMed
24.
go back to reference Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, Uchida M, Ogata N, Seichi A, Nakamura K, Kawaguchi H: Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005, 13: 632-641. 10.1016/j.joca.2005.03.004.CrossRefPubMed Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, Uchida M, Ogata N, Seichi A, Nakamura K, Kawaguchi H: Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005, 13: 632-641. 10.1016/j.joca.2005.03.004.CrossRefPubMed
25.
go back to reference Sampson ER, Beck CA, Ketz J, Canary KL, Hilton MJ, Awad H, Schwarz EM, Chen D, O'Keefe RJ, Rosier RN, Zuscik MJ: Establishment of an index with increased sensitivity for assessing murine arthritis. J Orthop Res. 2011, 29: 1145-1151. 10.1002/jor.21368.PubMedCentralCrossRefPubMed Sampson ER, Beck CA, Ketz J, Canary KL, Hilton MJ, Awad H, Schwarz EM, Chen D, O'Keefe RJ, Rosier RN, Zuscik MJ: Establishment of an index with increased sensitivity for assessing murine arthritis. J Orthop Res. 2011, 29: 1145-1151. 10.1002/jor.21368.PubMedCentralCrossRefPubMed
26.
go back to reference Glasson SS, Blanchet TJ, Morris EA: The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 2007, 15: 1061-1069. 10.1016/j.joca.2007.03.006.CrossRefPubMed Glasson SS, Blanchet TJ, Morris EA: The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 2007, 15: 1061-1069. 10.1016/j.joca.2007.03.006.CrossRefPubMed
27.
go back to reference Glasson SS, Chambers MG, Van Den Berg WB, Little CB: The OARSI histopathology initiative: recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010, 18 (Suppl 3): S17-23.CrossRefPubMed Glasson SS, Chambers MG, Van Den Berg WB, Little CB: The OARSI histopathology initiative: recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010, 18 (Suppl 3): S17-23.CrossRefPubMed
28.
go back to reference Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O'Brien T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ, Zuscik MJ, Rosier RN: Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum. 2008, 58: 3132-3144. 10.1002/art.23946.PubMedCentralCrossRefPubMed Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O'Brien T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ, Zuscik MJ, Rosier RN: Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum. 2008, 58: 3132-3144. 10.1002/art.23946.PubMedCentralCrossRefPubMed
29.
go back to reference Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN: Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 1988, 37: 1163-1167. 10.2337/diabetes.37.9.1163.CrossRefPubMed Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN: Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 1988, 37: 1163-1167. 10.2337/diabetes.37.9.1163.CrossRefPubMed
30.
go back to reference Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ: Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008, 31: 1473-1478. 10.2337/dc08-0545.PubMedCentralCrossRefPubMed Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ: Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008, 31: 1473-1478. 10.2337/dc08-0545.PubMedCentralCrossRefPubMed
31.
go back to reference Silberberg M, Silberberg R: Osteoarthrosis in mice fed diets enriched with animal or vegetable fat. Arch Pathol. 1960, 70: 385-390.PubMed Silberberg M, Silberberg R: Osteoarthrosis in mice fed diets enriched with animal or vegetable fat. Arch Pathol. 1960, 70: 385-390.PubMed
32.
go back to reference Silberberg R, Silberberg M: Skeletal growth and articular changes in mice receiving a high-fat diet. Am J Pathol. 1950, 26: 113-131. incl 114 plPubMedCentralPubMed Silberberg R, Silberberg M: Skeletal growth and articular changes in mice receiving a high-fat diet. Am J Pathol. 1950, 26: 113-131. incl 114 plPubMedCentralPubMed
33.
go back to reference Silberberg M, Silberberg R: Degenerative joint disease in mice fed a high-fat diet at various ages. Exp Med Surg. 1952, 10: 76-87.PubMed Silberberg M, Silberberg R: Degenerative joint disease in mice fed a high-fat diet at various ages. Exp Med Surg. 1952, 10: 76-87.PubMed
34.
go back to reference Sharma L, Song J, Felson DT, Cahue S, Shamiyeh E, Dunlop DD: The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA. 2001, 286: 188-195. 10.1001/jama.286.2.188.CrossRefPubMed Sharma L, Song J, Felson DT, Cahue S, Shamiyeh E, Dunlop DD: The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA. 2001, 286: 188-195. 10.1001/jama.286.2.188.CrossRefPubMed
35.
go back to reference Felson DT, Goggins J, Niu J, Zhang Y, Hunter DJ: The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum. 2004, 50: 3904-3909. 10.1002/art.20726.CrossRefPubMed Felson DT, Goggins J, Niu J, Zhang Y, Hunter DJ: The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum. 2004, 50: 3904-3909. 10.1002/art.20726.CrossRefPubMed
36.
go back to reference Silveri F, Brecciaroli D, Argentati F, Cervini C: Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol. 1994, 21: 1899-1902.PubMed Silveri F, Brecciaroli D, Argentati F, Cervini C: Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol. 1994, 21: 1899-1902.PubMed
37.
go back to reference Dahaghin S, Bierma-Zeinstra SM, Koes BW, Hazes JM, Pols HA: Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis. 2007, 66: 916-920. 10.1136/ard.2005.045724.PubMedCentralCrossRefPubMed Dahaghin S, Bierma-Zeinstra SM, Koes BW, Hazes JM, Pols HA: Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis. 2007, 66: 916-920. 10.1136/ard.2005.045724.PubMedCentralCrossRefPubMed
38.
go back to reference Douloumpakas I, Pyrpasopoulou A, Triantafyllou A, Sampanis C, Aslanidis S: Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: a pilot study. Hippokratia. 2007, 11: 216-218.PubMedCentralPubMed Douloumpakas I, Pyrpasopoulou A, Triantafyllou A, Sampanis C, Aslanidis S: Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: a pilot study. Hippokratia. 2007, 11: 216-218.PubMedCentralPubMed
39.
go back to reference Hart DJ, Doyle DV, Spector TD: Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol. 1995, 22: 1118-1123.PubMed Hart DJ, Doyle DV, Spector TD: Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol. 1995, 22: 1118-1123.PubMed
40.
go back to reference Silberberg M: Effects of a high fat diet on the joints of aging mice. Arch Pathol. 1950, 50: 828-846. Silberberg M: Effects of a high fat diet on the joints of aging mice. Arch Pathol. 1950, 50: 828-846.
41.
go back to reference Griffin TM, Fermor B, Huebner JL, Kraus VB, Rodriguiz RM, Wetsel WC, Cao L, Setton LA, Guilak F: Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther. 2010, 12: R130-10.1186/ar3068.PubMedCentralCrossRefPubMed Griffin TM, Fermor B, Huebner JL, Kraus VB, Rodriguiz RM, Wetsel WC, Cao L, Setton LA, Guilak F: Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther. 2010, 12: R130-10.1186/ar3068.PubMedCentralCrossRefPubMed
42.
go back to reference Silberberg M, Silberberg R: Role of thyroid hormone in the pathogenesis of joint disease in mice: effects of radiothyroidectomy and high-fat diets. J Bone Joint Surg Am. 1955, 37-A: 537-548.PubMed Silberberg M, Silberberg R: Role of thyroid hormone in the pathogenesis of joint disease in mice: effects of radiothyroidectomy and high-fat diets. J Bone Joint Surg Am. 1955, 37-A: 537-548.PubMed
43.
go back to reference Sokoloff L, Mickelsen O, Silverstein E, Jay GE, Yamamoto RS: Experimental obesity and osteoarthritis. Am J Physiol. 1960, 198: 765-770.PubMed Sokoloff L, Mickelsen O, Silverstein E, Jay GE, Yamamoto RS: Experimental obesity and osteoarthritis. Am J Physiol. 1960, 198: 765-770.PubMed
44.
go back to reference Sokoloff L, Mickelsen O: Dietary fat supplements, body weight and osteoarthritis in Dba-2jn mice. J Nutr. 1965, 85: 117-121.PubMed Sokoloff L, Mickelsen O: Dietary fat supplements, body weight and osteoarthritis in Dba-2jn mice. J Nutr. 1965, 85: 117-121.PubMed
45.
go back to reference Griffin TM, Huebner JL, Kraus VB, Guilak F: Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum. 2009, 60: 2935-2944. 10.1002/art.24854.PubMedCentralCrossRefPubMed Griffin TM, Huebner JL, Kraus VB, Guilak F: Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum. 2009, 60: 2935-2944. 10.1002/art.24854.PubMedCentralCrossRefPubMed
46.
go back to reference Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN: Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes. 1991, 40: 82-87. 10.2337/diabetes.40.1.82.CrossRefPubMed Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN: Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes. 1991, 40: 82-87. 10.2337/diabetes.40.1.82.CrossRefPubMed
47.
go back to reference Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism. 1995, 44: 645-651. 10.1016/0026-0495(95)90123-X.CrossRefPubMed Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism. 1995, 44: 645-651. 10.1016/0026-0495(95)90123-X.CrossRefPubMed
48.
go back to reference Silberberg M, Silberberg R, Orcutt B: Modifying effect of linoleic acid on articular aging and osteoarthrosis in lard-fed mice. Gerontologia. 1965, 11: 179-187. 10.1159/000211491.CrossRefPubMed Silberberg M, Silberberg R, Orcutt B: Modifying effect of linoleic acid on articular aging and osteoarthrosis in lard-fed mice. Gerontologia. 1965, 11: 179-187. 10.1159/000211491.CrossRefPubMed
49.
go back to reference Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B: n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem. 2000, 275: 721-724. 10.1074/jbc.275.2.721.CrossRefPubMed Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B: n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem. 2000, 275: 721-724. 10.1074/jbc.275.2.721.CrossRefPubMed
50.
go back to reference Curtis CL, Rees SG, Cramp J, Flannery CR, Hughes CE, Little CB, Williams R, Wilson C, Dent CM, Harwood JL, Caterson B: Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc. 2002, 61: 381-389. 10.1079/PNS2002174.CrossRefPubMed Curtis CL, Rees SG, Cramp J, Flannery CR, Hughes CE, Little CB, Williams R, Wilson C, Dent CM, Harwood JL, Caterson B: Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc. 2002, 61: 381-389. 10.1079/PNS2002174.CrossRefPubMed
51.
go back to reference Chapkin RS, Kim W, Lupton JR, McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009, 81: 187-191. 10.1016/j.plefa.2009.05.010.PubMedCentralCrossRefPubMed Chapkin RS, Kim W, Lupton JR, McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009, 81: 187-191. 10.1016/j.plefa.2009.05.010.PubMedCentralCrossRefPubMed
52.
go back to reference Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N: Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr. 2010, 140: 1915-1922. 10.3945/jn.110.125732.CrossRefPubMed Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N: Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr. 2010, 140: 1915-1922. 10.3945/jn.110.125732.CrossRefPubMed
Metadata
Title
High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury
Authors
Robert A Mooney
Erik R Sampson
Jaclyn Lerea
Randy N Rosier
Michael J Zuscik
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3529

Other articles of this Issue 6/2011

Arthritis Research & Therapy 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.